These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Incidence of cystic fibrosis in five different states of Brazil as determined by screening of p.F508del, mutation at the CFTR gene in newborns and patients. Raskin S; Pereira-Ferrari L; Reis FC; Abreu F; Marostica P; Rozov T; Cardieri J; Ludwig N; Valentin L; Rosario-Filho NA; Camargo Neto E; Lewis E; Giugliani R; Diniz EM; Culpi L; Phillip JA; Chakraborty R J Cyst Fibros; 2008 Jan; 7(1):15-22. PubMed ID: 17544945 [TBL] [Abstract][Full Text] [Related]
26. Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study. Marson FA; Bertuzzo CS; Ribeiro AF; Ribeiro JD BMC Med Genet; 2014 Mar; 15():27. PubMed ID: 24593045 [TBL] [Abstract][Full Text] [Related]
27. Cystic fibrosis in Iceland and the high prevalence of the N1303K variant. Elidottir H; Bjarnadottir SR; Baldursson O; Jonsdottir B Pediatr Pulmonol; 2024 Jul; 59(7):1944-1951. PubMed ID: 38629430 [TBL] [Abstract][Full Text] [Related]
28. Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation. De Stefano D; Villella VR; Esposito S; Tosco A; Sepe A; De Gregorio F; Salvadori L; Grassia R; Leone CA; De Rosa G; Maiuri MC; Pettoello-Mantovani M; Guido S; Bossi A; Zolin A; Venerando A; Pinna LA; Mehta A; Bona G; Kroemer G; Maiuri L; Raia V Autophagy; 2014; 10(11):2053-74. PubMed ID: 25350163 [TBL] [Abstract][Full Text] [Related]
29. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype. Parad RB; Gerard CJ; Zurakowski D; Nichols DP; Pier GB Infect Immun; 1999 Sep; 67(9):4744-50. PubMed ID: 10456926 [TBL] [Abstract][Full Text] [Related]
30. The novel complex allele [A238V;F508del] of the CFTR gene: clinical phenotype and possible implications for cystic fibrosis etiological therapies. Diana A; Polizzi AM; Santostasi T; Ratclif L; Pantaleo MG; Leonetti G; Iusco DR; Gallo C; Conese M; Manca A J Hum Genet; 2016 Jun; 61(6):473-81. PubMed ID: 26911355 [TBL] [Abstract][Full Text] [Related]
31. p.F508del in a heterogeneous cystic fibrosis population from Minas Gerais, Brazil. Vidigal PV; Reis FJ; Boson WL; De Marco LA; Brasileiro-Filho G Braz J Med Biol Res; 2008 Aug; 41(8):643-7. PubMed ID: 18797695 [TBL] [Abstract][Full Text] [Related]
32. Classic respiratory disease but atypical diagnostic testing distinguishes adult presentation of cystic fibrosis. Keating CL; Liu X; Dimango EA Chest; 2010 May; 137(5):1157-63. PubMed ID: 19965956 [TBL] [Abstract][Full Text] [Related]
33. Lessons learned from 20 years of newborn screening for cystic fibrosis. Massie RJ; Curnow L; Glazner J; Armstrong DS; Francis I Med J Aust; 2012 Jan; 196(1):67-70. PubMed ID: 22256939 [TBL] [Abstract][Full Text] [Related]
34. Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations. Padoan R; Bassotti A; Seia M; Corbetta C Eur J Pediatr; 2002 Apr; 161(4):212-5. PubMed ID: 12014388 [TBL] [Abstract][Full Text] [Related]
35. Familial concordance of phenotype and microbial variation among siblings with CF. Picard E; Aviram M; Yahav Y; Rivlin J; Blau H; Bentur L; Avital A; Villa Y; Schwartz S; Kerem B; Kerem E Pediatr Pulmonol; 2004 Oct; 38(4):292-7. PubMed ID: 15334505 [TBL] [Abstract][Full Text] [Related]
36. Unraveling the complex genetic model for cystic fibrosis: pleiotropic effects of modifier genes on early cystic fibrosis-related morbidities. Li W; Soave D; Miller MR; Keenan K; Lin F; Gong J; Chiang T; Stephenson AL; Durie P; Rommens J; Sun L; Strug LJ Hum Genet; 2014 Feb; 133(2):151-61. PubMed ID: 24057835 [TBL] [Abstract][Full Text] [Related]
37. Characterisation of mutations and genotype-phenotype correlation in cystic fibrosis: experience from India. Shastri SS; Kabra M; Kabra SK; Pandey RM; Menon PS J Cyst Fibros; 2008 Mar; 7(2):110-5. PubMed ID: 17716958 [TBL] [Abstract][Full Text] [Related]
38. Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR. Donaldson SH; Pilewski JM; Griese M; Cooke J; Viswanathan L; Tullis E; Davies JC; Lekstrom-Himes JA; Wang LT; Am J Respir Crit Care Med; 2018 Jan; 197(2):214-224. PubMed ID: 28930490 [TBL] [Abstract][Full Text] [Related]
39. Outcomes of a cystic fibrosis carrier testing clinic for couples. Christie LM; Ingrey AJ; Turner GM; Proos AL; Watts GE Med J Aust; 2009 Nov; 191(9):499-501. PubMed ID: 19883345 [TBL] [Abstract][Full Text] [Related]
40. Long-term effects of birth order and age at diagnosis in cystic fibrosis: a sibling cohort study. Slieker MG; van den Berg JM; Kouwenberg J; van Berkhout FT; Heijerman HG; van der Ent CK Pediatr Pulmonol; 2010 Jun; 45(6):601-7. PubMed ID: 20503286 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]